The Future of Lyme and Tickborne Disease Therapeutics
On May 14, 2026, Center for Lyme Action will host a live public educational event in Washington, D.C. focused on the current and future of Lyme and tick-borne disease therapeutics.
While the treatment of acute Lyme disease, is usually successful with current antibiotic therapies, chronic Lyme disease does not have any FDA approved treatments leaving patients with few options and little access to care.
Where: 2044 Rayburn House Office Building, Washington, D.C.
When: Thursday May 14, 2026 from 5-7:00pm, doors open at 4:30pm
Format: In-person only. No fee to attend.
Agenda
- Welcome
- Opening Remarks by Members of Congress
- The State of Lyme Disease Therapeutic Research – Nicole Bell, CEO Galaxy Diagnostics
- Lyme Clinical Trials Network – Dr. Brian Fallon, Director, Clinical Trials Network
- Q&A
A reception will follow the event from 6:00 – 7:00pm.
We look forward to seeing you in Washington, DC!
EVENT SUMMARY
Congressional Series: Therapeutics
Location: 2044 Rayburn House Office Building
Washington, DC 20515
In Person Only
May 14, 2026 5:00 – 7:00 pm
Reception 6:00 – 7:00pm
PAST EVENTS
Click here to see our previous events
611 Pennsylvania Ave, SE
Suite #126
Washington, DC 20003